CLINICAL_TRIALS
research
· 2018-05-21
Clinical Trial Update: Cell Free DNA and Its Integrity Using ALU Sequences as a Biomarker for Diagnosis of Breast Cancer
Summary
This study investigates whether cell-free DNA integrity, measured using ALU sequences, can serve as a biomarker for diagnosing breast cancer; the current trial …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assiut University | Conditions: Breast Cancer | Status: UNKNOWN